A Proposal of a Personalized Surveillance Strategy for Gastric Cancer: A Retrospective Analysis of 9191 Patients

被引:12
作者
Pan, Si-wei [1 ]
Wang, Peng-liang [1 ]
Huang, Han-wei [1 ]
Luo, Lei [1 ]
Wang, Xin [1 ]
Wang, Tao [1 ]
Liu, Fu-nan [1 ]
Xu, Hui-mian [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang 110001, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
INTENSIVE FOLLOW-UP; PROGNOSTIC-SIGNIFICANCE; CONDITIONAL SURVIVAL; CURATIVE SURGERY; GASTRECTOMY; RESECTION;
D O I
10.1155/2019/3248727
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. In gastric cancer, various surveillance strategies are suggested in international guidelines. The current study is intended to evaluate the current strategies and provide more personalized proposals for personalized cancer medicine. Materials and Methods. In the aggregate, 9191 patients with gastric cancer after gastrectomy from 1998 to 2009 were selected from the Surveillance, Epidemiology, and End Results database. Disease-specific survival was analyzed by Kaplan-Meier method and the log-rank test. Cox proportional hazards regression analyses were used to confirm the independent prognostic factors. As well, hazard ratio (HR) curves were used to compare the risk of death over time. Conditional survival (CS) was applied to dynamically assess the prognosis after each follow-up. Results. Comparisons from HR curves on different stages showed that earlier stages had distinctly lower HR than advanced stages. The curve of stage IIA was flat and more likely the same as that of stage I while that of stage IIB is like that of stage III with an obvious peak. After estimating CS at intervals of three months, six months, and 12 months in different periods, stages I and IIA had high levels of CS all along, while there were visible differences among CS levels of stages IIB and III. Conclusions. The frequency of follow-up for early stages, like stages I and IIA, could be every six months or longer in the first three years and annually thereafter. And those with unfavorable conditions, such as stages IIB and III, could be followed up much more frequently and sufficiently than usual.
引用
收藏
页数:9
相关论文
共 33 条
[11]   A longitudinal assessment of psychological distress after oesophageal cancer surgery [J].
Hellstadius, Ylva ;
Lagergren, Jesper ;
Zylstra, Janine ;
Gossage, James ;
Davies, Andrew ;
Hultman, Christina M. ;
Lagergren, Pernilla ;
Wikman, Anna .
ACTA ONCOLOGICA, 2017, 56 (05) :746-752
[12]   Japanese gastric cancer treatment guidelines 2014 (ver. 4) [J].
Japanese Gastric Cancer Association .
GASTRIC CANCER, 2017, 20 (01) :1-19
[13]   Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy [J].
Kawamura, Yuichiro ;
Satoh, Seiji ;
Umeki, Yusuke ;
Ishida, Yoshinori ;
Suda, Koichi ;
Uyama, Ichiro .
SPRINGERPLUS, 2016, 5
[14]  
Khin M. O., 2018, BMJ-BRIT MED J, V29
[15]   Active Surveillance, Quality of Life, and Cancer-related Anxiety [J].
Klotz, Laurence .
EUROPEAN UROLOGY, 2013, 64 (01) :37-39
[16]   Conditional survival analysis in Korean patients with gastric cancer undergoing curative gastrectomy [J].
Lee, Jin Won ;
Ali, Bandar ;
Yoo, Han Mo ;
Park, Cho Hyun ;
Song, Kyo Young .
BMC CANCER, 2015, 15
[17]   The role of follow-up endoscopy after total gastrectomy for gastric cancer [J].
Lee, SY ;
Lee, JH ;
Hwang, NC ;
Kim, YH ;
Rhee, PL ;
Kim, JJ ;
Paik, SW ;
Rhee, JC ;
Sohn, TS ;
Kim, S .
EJSO, 2005, 31 (03) :265-269
[18]   Postgastrectomy follow-up in the West: evidence base, guidelines, and daily practice [J].
Nilsson, Magnus .
GASTRIC CANCER, 2017, 20 :S135-S140
[19]   Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial [J].
Noh, Sung Hoon ;
Park, Sook Ryun ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Chung, Ik-Joo ;
Kim, Sang-Woon ;
Kim, Hyung-Ho ;
Choi, Jin-Hyuk ;
Kim, Hoon-Kyo ;
Yu, Wansik ;
Lee, Jong Inn ;
Shin, Dong Bok ;
Ji, Jiafu ;
Chen, Jen-Shi ;
Lim, Yunni ;
Ha, Stella ;
Bang, Yung-Jue .
LANCET ONCOLOGY, 2014, 15 (12) :1389-1396
[20]   Global cancer statistics, 2002 [J].
Parkin, DM ;
Bray, F ;
Ferlay, J ;
Pisani, P .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108